Cargando…
LOX family and ZFPM2 as novel diagnostic biomarkers for malignant pleural mesothelioma
BACKGROUND: Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer that develops in the pleural and outer layer of tissues surrounding the lungs. MPM is primarily caused by occupational exposure to asbestos and results in a poor prognosis. Effective therapeutics as well as early diagno...
Autores principales: | Kim, Min-Kyu, Kim, Hyun-won, Jang, Mirae, Oh, Sung Soo, Yong, Suk-Joong, Jeong, Yangsik, Jung, Soon-Hee, Choi, Jong-Whan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950830/ https://www.ncbi.nlm.nih.gov/pubmed/31921422 http://dx.doi.org/10.1186/s40364-019-0180-0 |
Ejemplares similares
-
Diagnostic imaging and workup of malignant pleural mesothelioma
por: Cardinale, Luciano, et al.
Publicado: (2017) -
Ancillary Diagnostic Investigations in Malignant Pleural Mesothelioma
por: Dipper, Alex, et al.
Publicado: (2021) -
Diagnostic and Therapeutic Challenges of Malignant Pleural Mesothelioma
por: Moro, Jacopo, et al.
Publicado: (2022) -
Preliminary results of entire pleural intensity-modulated radiotherapy in a neoadjuvant setting for resectable malignant mesothelioma
por: Hong, Ji Hyun, et al.
Publicado: (2019) -
Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)